Caprock Group’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.48M Sell
8,600
-2,410
-22% -$447K 0.04% 436
2025
Q4
$2.2M Sell
11,010
-353
-3% -$64K 0.05% 350
2025
Q3
$1.86M Buy
+11,363
New +$1.8M 0.05% 368
2025
Q1
$776K Buy
+5,158
New +$865K 0.02% 549
2022
Q4
Sell
-1,120
Closed -$220K 569
2022
Q3
$220K Sell
1,120
-161
-13% -$34.8K 0.02% 494
2022
Q2
$274K Buy
+1,281
New +$313K 0.03% 409
2021
Q4
Sell
-1,060
Closed -$437K 589
2021
Q3
$437K Buy
1,060
+152
+17% +$63.1K 0.04% 290
2021
Q2
$336K Buy
908
+14
+2% +$4.67K 0.03% 334
2021
Q1
$259K Buy
894
+42
+5% +$11.7K 0.03% 383
2020
Q4
$213K Buy
+852
New +$203K 0.02% 428
2020
Q1
Sell
-1,442
Closed -$220K 374
2019
Q4
$220K Sell
1,442
-332
-19% -$46K 0.04% 311
2019
Q3
$235K Hold
1,774
0.05% 284
2019
Q2
$252K Hold
1,774
0.05% 261
2019
Q1
$258K Sell
1,774
-45
-2% -$5.91K 0.05% 287
2018
Q4
$206K Hold
1,819
0.05% 313
2018
Q3
$245K Hold
1,819
0.05% 315
2018
Q2
$204K Sell
1,819
-160
-8% -$17.3K 0.04% 392
2018
Q1
$211K Hold
1,979
0.05% 382
2017
Q4
$208K Sell
1,979
-1,470
-43% -$160K 0.04% 417
2017
Q3
$373K Buy
+3,449
New +$354K 0.08% 236

Other funds holding CRL